To obtain further direct experimental evidence supporting these hypotheses, here, we wished to evaluate the effect of SOS1 and/or SOS2 genetic ablation in a mouse model of p210BCR/ABL-driven CML and derived cell lines. This evidence concerns the gene SOS2 and chronic myelogenous leukemia, BCR-ABL1 positive.